FRIDAY, May 3 (HealthDay News) -- The number of testicular
cancer cases continues to climb slowly but steadily in the United
States, according to new research.
While the cancer is still most common among white males, the
greatest increase is among Hispanic men, according to Dr. Scott
Eggener, an associate professor of surgery at the University of
Eggener tracked the statistics on testicular cancer from 1992
through 2009, looking at data from a nationwide epidemiology
"The incidence of testicular cancer appears to be increasing very slowly but steadily among virtually all groups that we studied," he said. "The novel finding is that the most dramatic increase is in Hispanic men."
Eggener can't explain the increase. He is due to present his
findings Monday at the annual meeting of the American Urological
Association, in San Diego. The data and conclusions should be
viewed as preliminary until published in a peer-reviewed
The U.S. National Institute of Diabetes and Digestive and Kidney
Diseases supported the study.
Testicular cancer is known as a young man's cancer, as half of
the cases affect men aged 20 to 34, according to the American
Cancer Society. However, older men can also be affected.
This year, the American Cancer Society expects 7,920 new cases
of testicular cancer in the United States. About 370 men are
expected to die of it.
"It still remains an uncommon cancer," said Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society. He reviewed the new findings. "It's important that we become aware of the situation [of rising numbers of cases], but not become alarmed by it." Hispanic men, he noted, still have a lower rate of the cancer than do white men.
In his study, Eggener found that the incidence of testicular
cancer rose from 1992 through 2009. In 1992, for instance, 5.7 of
every 100,000 men had testicular cancer. By 2009, that number had
risen to 6.8 men for every 100,000.
Hispanic men had the largest annual percentage increase. In
1992, four of every 100,000 Hispanic men were affected. By 2009, it
was 6.3 men of every 100,000, the investigators found.
For men affected, the outlook is generally good, experts agreed.
"It has the highest survival rate of any solid tumor," Eggener
said. The overall five-year survival rate, he noted, is 95 percent
Symptoms can include a painless lump on a testicle, an enlarged
testicle or an achy feeling in the lower belly.
Few risk factors have been identified. One known risk factor is
having an undescended testicle -- one that does not move down into
the scrotum at birth. In the United States, those born with an
undescended testicle commonly have corrective surgery, Eggener
Currently, the U.S. Preventive Services Task Force, a national
panel of experts, does not recommend routine testicular self-exams.
It concludes that screenings performed by health care providers or
men ''are unlikely to provide meaningful health benefits because of
the low incidence and high survival rate of testicular cancer, even
when it is detected at symptomatic stages."
Nor does the cancer society recommend routine monthly
self-exams, Lichtenfeld said. "Clearly the task force has looked at
this very carefully and they recommend not doing testicular
self-exam or any form of screening for testicular cancer.''
According to the cancer society, testicular exam should be part
of a routine exam by a health care provider, Lichtenfeld said.
It's important for men to pay attention to any changes in their
testicles, he said.
"If a man notices a lump or a change, he should go see his doctor," Lichtenfeld said. "We have had a significant improvement in the treatment of this cancer."
To learn more about testicular cancer, visit the
American Cancer Society.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.